Back
Ligand Pharmaceuticals 10K Form
Sell
47
LGND
Ligand Pharmaceuticals
Last Price:
$101.79
Seasonality Move:
2.02%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | LGND/Ligand Pharmaceuticals Quarterly |
| 2023-11-09 | 10Q | LGND/Ligand Pharmaceuticals Quarterly |
| 2023-08-09 | 10Q | LGND/Ligand Pharmaceuticals Quarterly |
| 2023-05-08 | 10Q | LGND/Ligand Pharmaceuticals Quarterly |
| 2022-11-08 | 10Q | LGND/Ligand Pharmaceuticals Quarterly |
| 2022-08-09 | 10Q | LGND/Ligand Pharmaceuticals Quarterly |
Receive LGND News And Ratings
See the #1 stock for the next 7 days that we like better than LGND
LGND Financial Statistics
Sales & Book Value
| Annual Sales: | $167.1M |
|---|---|
| Cash Flow: | $-27.5M |
| Price / Cash Flow: | 56 |
| Annual Sales: | $41.27 |
| Price / Book: | 2.46 |
Profitability
| EPS (TTM): | -7.12000 |
|---|---|
| Net Income (TTM): | $-132.6M |
| Gross Margin: | $156.1M |
| Return on Equity: | -16.38% |
| Return on Assets: | -14.47% |
Ligand Pharmaceuticals Earnings Forecast
Key Ligand Pharmaceuticals Financial Ratios
-
The Gross Profit Margin over the past 31 years for LGND is 93.37%.
-
The Selling, General & Administrative Expenses for LGND have been equal to 47.06% of Gross Profit Margin.
-
The Research & Development expenses have been 12.82% of Revenue.
-
The Net Earning history of LGND is -2.41% of Total Revenues.
-
Per Share Earnings over the last 31 years have been positive in 19 years.
Ligand Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | LGND |
| CUSIP: | 53220K |
| Website: | ligand.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.27 |
| Quick Ratio: | 4.29 |
Price-to-Earnings
| Trailing P/E Ratio: | 39.38 |
|---|---|
| Forward P/E Ratio: | 14.49 |
LGND Technical Analysis vs Fundamental Analysis
Sell
47
Ligand Pharmaceuticals (LGND)
is a Sell
Is Ligand Pharmaceuticals a Buy or a Sell?
-
Ligand Pharmaceuticals stock is rated a SellThe current Ligand Pharmaceuticals [LGND] share price is $101.29. The Score for LGND is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.